|Day Low/High||4.40 / 4.44|
|52 Wk Low/High||3.60 / 6.06|
Sanofi and its specialty care global business unit Sanofi Genzyme announced today positive new six-year investigational data from the extension study of Lemtrada ® (alemtuzumab) in patients with relapsing...
Sanofi Genzyme, the specialty care global business unit of Sanofi, today announced positive new real-world data from the Phase 4 Teri-PRO (Patient Reported Outcomes) study of Aubagio ® (teriflunomide), a...
Here's a technical look at how to trade some of the most active stocks on the market right now.
- Joshua Riff, M.D., Named Chief Executive Officer -
Visa steps up its game in the blockchain technology space, inviting banks to join its European innovation hub in testing a cross-border settlement platform with BLT Group.
Monte dei Paschi, of Italy, Spain's Ibercaja and U.K. "challengers" could find themselves targets.
Deutsche Bank, Banco Santander, and Bank of New York Mellon are teaming with broker ICAP, technology company Clearmatics, and UBS Investment Bank to create a "utility settlement coin."
The technology could mean banks would not necessarily have to move to the E.U.
The technology could mean banks would not necessarily have to move to the EU.
ABN Amro shares rise by 5% after strong second-quarter results.
The Big 6 U.K. bank will focus on regulatory challenges following the Brexit vote.
Lloyds emerges as the clear winner in the U.K., while on mainland Europe UBS pulls further ahead of Credit Suisse despite return on equity niggles.
STB TK SAN are going ex-dividend tomorrow, Wednesday, July 27, 2016
- World's largest influenza vaccine manufacturer expects to distribute more than 65 million vaccine doses to help protect people six months and older against the flu -
Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today that the first adult patient has enrolled and been dosed in a pivotal Phase 2/3 clinical trial named ASCEND for the investigational...
A passing grade is essentially a green light for financial institutions to boost capital deployment programs.
There's a reason it is buying its own stock hand over fist.
U.S. stock futures are pointing to a third day of gains on Wall Street.
The U.S. units of the two European lenders were the only failures in the latest stress tests.
Figures paint a picture of weak consumer demand in Europe's three largest economies.
Morgan Stanley passed this year's Federal Reserve "stress tests" -- with a footnote. The firm can proceed with dividends and share buybacks but must fix certain weaknesses.
The U.S. units of Deutsche Bank and Banco Santander continue to have problems, while Morgan Stanley must resubmit its capital distribution plan by the end of December or fail.
Despite shares of Banco Santander (SAN) dropping in high-volume trade today, the bank reiterates its financial targets for the year.
Here's a technical look at how to trade some of the most active stock on the market right now.